Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 85

Similar articles for PubMed (Select 23166559)

1.

A case of acute pulmonary thromboembolism after taking tadalafil.

Lee J, Kwon JH, Lee CH, Lee SM, Yim JJ, Yoo CG, Kim YW, Han SK, Park YS.

Tuberc Respir Dis (Seoul). 2012 Oct;73(4):231-3. doi: 10.4046/trd.2012.73.4.231. Epub 2012 Oct 31.

2.

Pulmonary embolism after tadalafil ingestion.

Chen HC, Wang CS, Chuang SH, Wang CY.

Pharm World Sci. 2008 Oct;30(5):610-2. doi: 10.1007/s11096-008-9229-0. Epub 2008 Jun 13.

PMID:
18548330
3.

Cardiovascular safety update of Tadalafil: retrospective analysis of data from placebo-controlled and open-label clinical trials of Tadalafil with as needed, three times-per-week or once-a-day dosing.

Kloner RA, Jackson G, Hutter AM, Mittleman MA, Chan M, Warner MR, Costigan TM, Vail GM.

Am J Cardiol. 2006 Jun 15;97(12):1778-84. Epub 2006 Apr 27.

PMID:
16765134
4.

A once-daily dose of tadalafil for erectile dysfunction: compliance and efficacy.

Washington SL 3rd, Shindel AW.

Drug Des Devel Ther. 2010 Sep 7;4:159-71. Review.

5.
6.

Efficacy and safety of tadalafil 5, 10, and 20 mg in Japanese men with erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled study.

Nagao K, Kimoto Y, Marumo K, Tsujimura A, Vail GM, Watts S, Ishii N, Kamidono S.

Urology. 2006 Oct;68(4):845-51.

PMID:
17070365
7.

Long-term safety and tolerability of tadalafil in the treatment of erectile dysfunction.

Montorsi F, Verheyden B, Meuleman E, Jünemann KP, Moncada I, Valiquette L, Casabé A, Pacheco C, Denne J, Knight J, Segal S, Watkins VS.

Eur Urol. 2004 Mar;45(3):339-44; discussion 344-5.

PMID:
15036680
8.

2009 update on phosphodiesterase type 5 inhibitor therapy part 2: updates on optimal utilization for sexual concerns and rare toxicities in this class.

Shindel AW.

J Sex Med. 2009 Sep;6(9):2352-64; quiz 2365-6. doi: 10.1111/j.1743-6109.2009.01447.x.

PMID:
19735356
9.

The efficacy and safety of tadalafil in United States and Puerto Rican men with erectile dysfunction.

Seftel AD, Wilson SK, Knapp PM, Shin J, Wang WC, Ahuja S.

J Urol. 2004 Aug;172(2):652-7. Erratum in: J Urol. 2005 Feb;173(2):664.

PMID:
15247754
11.
12.

Optimal strategy for penile rehabilitation after robot-assisted radical prostatectomy based on preoperative erectile function.

Basal S, Wambi C, Acikel C, Gupta M, Badani K.

BJU Int. 2013 Apr;111(4):658-65. doi: 10.1111/j.1464-410X.2012.11487.x. Epub 2012 Nov 27.

PMID:
23186312
13.

Long-term safety and efficacy of tadalafil 5 mg dosed once daily in men with erectile dysfunction.

Porst H, Rajfer J, Casabé A, Feldman R, Ralph D, Vieiralves LF, Esler A, Wolka AM, Klise SR.

J Sex Med. 2008 Sep;5(9):2160-9. doi: 10.1111/j.1743-6109.2008.00935.x. Epub 2008 Jun 28.

PMID:
18557812
14.

Update on clinical trials of tadalafil demonstrates no increased risk of cardiovascular adverse events.

Jackson G, Kloner RA, Costigan TM, Warner MR, Emmick JT.

J Sex Med. 2004 Sep;1(2):161-7.

PMID:
16422970
15.

[Tadalafil for erectile dysfunction: excellent safety and tolerance].

Bai WJ.

Zhonghua Nan Ke Xue. 2009 Jan;15(1):92-5. Review. Chinese.

PMID:
19288756
16.

Efficacy and safety of tadalafil in a Western European population of men with erectile dysfunction.

Eardley I, Gentile V, Austoni E, Hackett G, Lembo D, Wang C, Beardsworth A.

BJU Int. 2004 Oct;94(6):871-7.

PMID:
15476525
17.

Efficacy and safety of on-demand tadalafil for the treatment of erectile dysfunction in South-East Asian men.

Guo YL, Zhu JC, Pan TM, Ding Q, Wang YX, Cheong NF, Lim E, Shen W, Venugopalan M, Chan M.

Int J Urol. 2006 Jun;13(6):721-7.

PMID:
16834650
18.

Efficacy of tadalafil in men with erectile dysfunction naïve to phosphodiesterase 5 inhibitor therapy compared with prior responders to sildenafil citrate.

Broderick GA, Donatucci CF, Hatzichristou D, Torres LO, Valiquette L, Zhao Y, Loughney K, Sides GD, Ahuja S.

J Sex Med. 2006 Jul;3(4):668-75.

PMID:
16839323
19.

A randomized, double-blind, placebo-controlled, parallel study to assess the efficacy and safety of once-a-day tadalafil in men with erectile dysfunction who are naïve to PDE5 inhibitors.

Montorsi F, Aversa A, Moncada I, Perimenis P, Porst H, Barker C, Shane MA, Sorsaburu S.

J Sex Med. 2011 Sep;8(9):2617-24. doi: 10.1111/j.1743-6109.2011.02353.x. Epub 2011 Jun 27.

PMID:
21707928
20.

Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses.

Brock GB, McMahon CG, Chen KK, Costigan T, Shen W, Watkins V, Anglin G, Whitaker S.

J Urol. 2002 Oct;168(4 Pt 1):1332-6. Erratum in: J Urol. 2005 Feb;173(2):664. Dosage error in published abstract; MEDLINE/PubMed abstract corrected.

PMID:
12352386
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk